Status:
UNKNOWN
Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Patient With Invasive Cervical Carcinoma
Patient With CIN Lesion
Eligibility:
FEMALE
25-55 years
Phase:
NA
Brief Summary
Cervical cancer the most frequent neoplasm and the fifth mortality rate of malignancies of the women in the world. It results in about 1,000 women in Taiwan and about 200,000 women worldwide dying of ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers
- People infected with HPV type 16 but without CIN lesions
- Patients with CIN lesions
- Patients with cervical cancer from National Taiwan University Hospital
- Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00673192
Start Date
January 1 2008
End Date
December 1 2008
Last Update
May 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100